Targeting type 2 immune activation beyond atopic dermatitis.

Leung, Donald Y M; Facheris, Paola; Veverka, Karen A; Cevikbas, Ferda; Guttman-Yassky, Emma

Leung, Donald Y M; Facheris, Paola; Veverka, Karen A; Cevikbas, Ferda; Guttman-Yassky, Emma.

Affiliation

Leung DYM; Pediatric Allergy and Clinical Immunology, Department of Pediatrics, National Jewish Health, Denver, Colorado. Electronic address: leungd@njhealth.org.
Facheris P; Department of Dermatology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Rozzano, Milan, Italy.
Veverka KA; ASLAN Pharmaceuticals, San Mateo, California.
Cevikbas F; ASLAN Pharmaceuticals, San Mateo, California.
Guttman-Yassky E; Dermatology and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, New York.

Ann Allergy Asthma Immunol ; 132(2): 121-123, 2024 Feb.

Article in En | MEDLINE | ID: mdl-37442541

Subject(s)

Dermatitis, Atopic; Humans; Skin; Cytokines

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Humans Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google